Harrison SA, Neff G, Guy CD, Bashir MR, et al. Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis. Gastroenterology 2020 Aug 8. pii: S0016-5085(20)35018.
PMID: 32781086